These 4 Measures Indicate That Allergy Therapeutics (LON:AGY) Is Using Debt Safely
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor...